Get the Stockscreener App
1.50
1.35%
0.02
Pre-market:
1.55
0.05
+3.33%
Precigen Inc stock is traded at $1.50, with a volume of 1.69M.
It is up +1.35% in the last 24 hours and up +9.49% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$1.48
Open:
$1.5
24h Volume:
1.69M
Relative Volume:
1.10
Market Cap:
$454.58M
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-3.8462
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
+5.63%
1M Performance:
+9.49%
6M Performance:
+91.03%
1Y Performance:
-6.83%
1-Day Range:
$1.48
$1.55
1-Week Range:
$1.38
$1.55
52-Week Range:
$0.6513
$2.17
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.50 | 454.58M | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.27 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
522.27 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.00 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.06 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
266.80 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
Closing Strong: Precigen Inc (PGEN) Ends at 1.42, Down -7.79 from Last Close - DWinneX
High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st
Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria
Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia
Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World
JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus
JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus
Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions - Yahoo Finance
Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings - Defense World
BNP Paribas Financial Markets Acquires New Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
ProShare Advisors LLC Buys 10,900 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World
D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Precigen, Inc. Reports Q1 2025 Financial Results - TipRanks
FY2025 EPS Estimates for Precigen Cut by Cantor Fitzgerald - Defense World
HC Wainwright Decreases Earnings Estimates for Precigen - Defense World
FY2027 EPS Estimates for Precigen Reduced by HC Wainwright - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World
Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus
JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria
JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia
Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com
Precigen Reports First Quarter 2025 Financial Results and Business Updates - StreetInsider
Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Precigen Inc (PGEN) Q1 2025 Earnings: Revenue Surges 26% to $1.4 - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Busine - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Business Updates | PGEN Stock News - GuruFocus
Barclays PLC Purchases 53,546 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen (PGEN) to Release Earnings on Tuesday - Defense World
Wells Fargo & Company MN Increases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen : to Announce First Quarter 2020 Financial Results on May 6th - marketscreener.com
Precigen Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
LPL Financial LLC Trims Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business Wire
There is no way Precigen Inc (PGEN) can keep these numbers up - Sete News
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Renaissance Technologies LLC - Defense World
Precigen Inc [PGEN] Insider Activity: An Update for Investors - knoxdaily.com
Precigen Inc (PGEN) stock analysis: A comprehensive overview - uspostnews.com
Geode Capital Management LLC Acquires 53,343 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
JPMorgan Chase & Co. Lowers Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Intrexon : Precigen Completes Series Of Transactions To Solidify Healthcare Focus - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precigen Inc Stock (PGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Perez Jeffrey Thomas | SVP, IP Affairs |
Aug 09 '24 |
Buy |
0.85 |
58,823 |
50,000 |
743,097 |
| KIRK RANDAL J | Director |
Aug 09 '24 |
Buy |
0.85 |
23,529,411 |
19,999,999 |
64,547,214 |
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):